Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.
about
Early alterations of brain cellular energy homeostasis in Huntington disease modelsA comprehensive review of amyotrophic lateral sclerosisComplementary and Alternative Therapies in Amyotrophic Lateral SclerosisDesign, power, and interpretation of studies in the standard murine model of ALSGlutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis modelsAnimal models and high field imaging and spectroscopyHighly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T.Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicineOne universal common endpoint in mouse models of amyotrophic lateral sclerosis.Targeting cellular energy production in neurological disorders.Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS diseaseTherapeutic developments in the treatment of amyotrophic lateral sclerosis.Antioxidants as treatment for neurodegenerative disorders.Nutrition and dietary supplements in motor neuron disease.Mitochondrial approaches for neuroprotectionCreatine in mouse models of neurodegeneration and aging.In sickness and in health: the widespread application of creatine supplementation.Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Creatine for neuroprotection in neurodegenerative disease: end of story?Beyond muscles: The untapped potential of creatine.Higher visceral fat is associated with lower cerebral N-acetyl-aspartate ratios in middle-aged adults.Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic TreatmentsHistological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats.The modulation of NMDA receptors and L-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test.Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats.Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system.A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction.Study of renal and hepatic toxicity in rats supplemented with creatine.Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1 mouse model: A H-magnetic resonance spectroscopic study
P2860
Q23912810-C4986962-ECEA-485F-9556-531B0DDD727DQ26775401-922D1026-C52A-4ED5-B722-123ABBAFF4A6Q26777929-8A979B81-88C5-42E5-922E-DCA6EF20B526Q28268686-ECED783A-5978-45ED-9928-F03658616546Q28572282-7D1ED643-18B3-4809-AACF-2A9422977047Q28662048-A0EA9A31-5167-4DB6-9843-ED1ABCC0028AQ30954808-D34B0EC3-B6B5-44A6-B78C-C47685FFEF40Q31002507-73ACF17D-CC78-46AC-85A2-A025C5535B55Q33757934-CA3311AC-72B1-4C68-AEA1-9F64C8AAE587Q33791877-E430EAEA-A418-4664-A918-DD5F81AD04C5Q33936763-6DCFFBC7-7BD7-44E3-8F80-B80ADA45A970Q34266266-511EE814-C1D3-4BE2-818D-FA382B7F6D25Q34474226-826CE1B0-415D-47D8-8AE4-1E7E3A4992C8Q34974850-CE1A0BDF-F39F-4707-AC96-7502FB825438Q34974866-972AE638-E843-4E0C-A6F6-62964CE393B5Q37073851-8A3B27A5-1849-4B67-A584-4C1A16FBD336Q37348590-28ED49DA-D651-43C0-9A26-528DF09C5BB2Q37851389-E21600A2-714A-49CC-A062-74BBB76020FDQ37958749-F53AB4F7-E18F-4336-94B0-09A2147E783BQ37960903-74C49756-9652-4D1A-B1C8-0D895637C4E8Q38573829-2648EBA2-4029-40AA-8DD8-79C31BBDA825Q38691246-78401A46-265B-4A3A-8EA1-DA57B96727DBQ38700215-E007D292-25D6-4361-A4C6-E5B83F242A64Q38763488-99FF829F-7E07-466A-BEE3-DB074DE868C5Q39101800-CD974172-93F1-48F0-AF56-C596D6CDE618Q39125775-8AAC5609-1712-4C92-8BF2-D8EFC84DCED5Q41630586-1C4F2BB2-659D-4F6B-BCDB-5E0B9B9CD35AQ42749841-1FB70847-8FFA-4D95-99E6-B16D4532BDCDQ43809083-086AF160-D463-4869-93BE-005931A10051Q44658205-1ACD3FD8-D41A-49E6-8E79-265B512171A7Q46767416-B871A55C-E719-400C-B9E7-477D92933CDAQ46851841-087CE3D5-32A2-4998-9062-7FAC96BD02F2Q49633688-905BC502-BDB4-4559-B66A-B5DAA1899795Q50032095-9C39BF41-4FC6-4906-A57D-A3E2C7E31CABQ53490055-0ABE28A7-36EA-45FF-A535-7899C51A5175Q58126926-38AF9D79-75F3-479D-A33C-BC92A0FFEB99
P2860
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Increases in cortical glutamat ...... d by creatine supplementation.
@en
Increases in cortical glutamat ...... d by creatine supplementation.
@nl
type
label
Increases in cortical glutamat ...... d by creatine supplementation.
@en
Increases in cortical glutamat ...... d by creatine supplementation.
@nl
prefLabel
Increases in cortical glutamat ...... d by creatine supplementation.
@en
Increases in cortical glutamat ...... d by creatine supplementation.
@nl
P2093
P2860
P50
P1476
Increases in cortical glutamat ...... ed by creatine supplementation
@en
P2093
B G Jenkins
M B Bogdanov
P2860
P304
P356
10.1046/J.1471-4159.2001.00188.X
P407
P577
2001-04-01T00:00:00Z